Effect of Ginseng total saponins on the cardiac performance in the rat. by Chan, Jenny Yuen-yi. & Chinese University of Hong Kong Graduate School. Division of Biochemistry.





B. Sc. (Hon.) Surrey, U.K.
A thesis submitted in partial fulfilment of












My thanks are due to more people than can be named
here, who have helped me during the past two years.
I wish to express my sincere gratitude to Dr H.W.
Yeung, Dr Anthony Koo and Dr David S.C. Tsang for their
valuable guidance throughout my graduate study, and much
helpful criticism and advice as regards to the original
text.
Special thanks are due to Mr K.W. Ho, Mr W.K. Hon, Mr
K.C. Chung and Miss Y.Y. Tam for their valuable assistance
in preparing the manuscript.
Last, but not least, I would like to express my
gratitude to Mrs W.W. Tam for her encouragement during this
research.
ABSTRACT
Panax ginseng has been used for centuries in
oriental medicine as a therapeutic and restorative tonic. A
variety of pharmacological actions has been ascribed to the
ginseng total saponins. In the present study a positive
inotropic effect of ginseng total saponins was demonstrated
in isolated perfused rat heart. The cardiac effect was
obtained in a Langendorff preparation perfused at 5-8
ml/min, 60-80 mm H9 when ginseng total saponins (0.3-3.5
mg/Kg) was bolus-injected into the perfusion medium.
Results showed that ginseng total saponins significantly
increased the cardiac contractility in a dose-dependent
manner and this effect was not blocked by cardiac selective
S blockers.
Biochemical studies revealed that ginseng extract
enhanced the influx of calcium into ventricular slices but
not into sarcoplasmic reticulum. Binding studies showed
that ginseng extract reduced the binding of
13H]dihydroalprenolol and [3H]adenosine to their respective
receptors. These findings taken together suggest that
ginseng total saponins increases cardiac contractility by
enhancing the influx of calcium under normal conditions.
However, in adversed conditions such as ischaemia and
hypoxia, ginseng may increase cardiac contractility by
interacting with adenosine receptors which alleviate the
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According to traditional Chinese medicine,
ginseng is believed to prolong and strengthen life, and
generally invigorate the body. Ginseng is the common name
for two main species of Panax herbs, both of which belong
to the Araliaceae family. The two species are: Panax
ginseng C.A. Meyer which grows in China, Korea and Japan and
Panax quinquefolium, which grows in North America.
Commerical available ginseng is either of the two forms,
white ginseng and red ginseng. White ginseng appears
ochroid in colour and is prepared from drying freshly
harvested roots in the sun after they are washed and
cleaned. Red ginseng is steamed root in reddish brown
colour.
1.1.1 Chemical studies of ginseng
Ginseng represents one of the most popular herbal
drugs in Chinese medicine. The roots and rhizomes of Panax
ginseng contain many constituents of pharmacological
interest. These include ginseng saponins, ginseng oil and
phytosterol, carbohydrates and sugar, organic acids,
2nitrogenous. substances, amino acids and peptides, vitamins
and minerals, and certain enzymes that have been isolated
and characterised (Shibata, 1967 Tanaka, 1973). Among
these, ginseng saponins are the principal constituents and
have attracted most interests. Chemical analyses,
therefore, have been focused on extraction, purification and
identification of these saponins. These constituents,
however, vary with species, places of origin, age of the
plant and the method of preparation. It is not surprising
that differences in therapeutic efficacy are quite often
observed with different ginseng roots.
The chemistry of the ginseng root has been
studied mainly by a group of Russian researchers under the
direction of I. Brekham and a Japanese group under the
direction of S. Shibata. The nomenclature for these ginseng
glycosides differs according to the Russian and Japanese
groups. Brekham's group isolated six saponins which they
called panaxosides. Based on the composition, these
glycosides are derived into two groups: Panaxosides A, B
and C belong to one group and yield a common non-sugar
substance (aglycone) called panaxatriol, while panaxosides
D, E, and F belong to another group that yield panaxadiol
after acid hydrolysis. None of the six panaxosides contains
identical sugar. on the other hand, Shibata and associates
called the saponins-- ginsenosides. In 1974, Shibata and
collaborators (Sanada sll.9 1974) successfully isolated
thirteen ginsenosides from ginsng root extract using two-
dimensional thin layer chronmatography. They are
The
ginsenosides from R o to R correlate with the increasing
values of the thin layer chromatography. Ginsenosides is
the least polar, having the lowest R value; whereas is
the most polar, having the highest R value. Among these
saponins, ginsenosid€ anc (R. group) anc nnrl
group) are found to be the main component of the
ginseng saponins.
At present nine of the total thirteen
ginsenosides have been characterised (Sanada££ al.,
1974a,b). Depending on the aglycone portion of the
molecule, these ginsenosides can be divided into three
groups. Ginsenoside R gives oleanolic acid, while
ginsenosides and R and R give panaxadiol,
c d
and ginsenosides R, R anda f give panaxatriol after
acid hydrolysis. Oleanolic acid is a pentacyclic,
oleanane-type triterpene compound. Ginsenosides R and R
group, on the other hand, are tetracyclic dammarane-typ€
triterpenes (Fi9ure 1-1).
The roots of Panax ginseng C-A- Meyer have been
used for centuries in oriental medicine as a therapeutic and
rochnrative tonic. A wide varieties of pharmacological
4Chemical structure of the triterpeneFigure 1.1
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5actions have been ascribed to ginseng. The most noticeable
are its effects on the central nervous system, endocrine
system, reproductive system, immune and cellul-ar system and
cardiovascular system (Wang, 1980).
There are diverse opinions in regards to the
effect of ginseng on the cardiovascular system. Often,
complicated and seemingly conflicting haemodynamics effect
of ginsenosides were described in the literature. For
example, Panax ginseng has been described as having either
hypotensive (Hsu, 1956) 9 hypertensive (Chang, 1959) or
biphasic effects on blood pressure of dogs and cats (Wood gt
-QI-, 1964 Chen at .p1., 1982a, b).
Perhaps one of the more thorough studies on the
cardiovascular actions of ginseng was that of Kaku et al
(1975) who investigated the individual effects of each
saponin. All of the saponins induced a bradycardia and had
a biphasic action on rat blood pressure when injected
intravenously in the anaethetised animal. There was little
effect on respiration. Hypotension preceded by slight
hypertension was seen. The pressor as well as depressor
action was not influenced by the pretreatment with atropine,
phentolamine or propranolol. Then, the effects seemed to be
due to the direct action of the saponin on the blood
vessels. Ginsenosides R and Re showed vasodilator activity
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in dogs, the potencies of which were 1/20th and 1/50th of
those of papaverine respectively. Ginsenosides RC and Rb2
showed very weak vasodilator activity, but R had no effect.
bi
Anaesthetised dogs, when injected intravenously with an
aqueous extract of ginseng (40 mg/K9) had their cardiac
outputs, strokes volumes and central venous pressure
significantly increased (Clifford 1978). From in
vitro work on the guinea-pig auricle and rabbit aorta it
seems that part of the action of ginseng in mediating
hypotension may be due to direct inhibition of myocardial
contractility which results from reduction of calcium influx
into the cardial cell and the inhibition of norepinephrine-
induced contractility of vascular smooth muscle (Hah al i
19785 Lee, 1980).
Recently it was reported that saponins provided
some protection against experimental myocardial infarction
in rabbits (Chen.££ ill., 1980). In order to elucidate the
mechanism of this action, the cardiovascular and
haemodynamic effects of ginsenosides were studied with
experiments in intact dogs. It was found that the extract
significantly reduced vertebral and femoral vascular
resistance but increased renal vascular resistance mainly by
decreasing renal blood flow (Chen££ .fll., 1982a,b). These
findings suggested that ginsenosides may produce different
responses in different blood vessels. The validity of this
assumption was later examined by evaluating the response to
ginsenosides of a variety of isolated blood vessels prepared
from rabbits, dogs and man (Chen Hi., 1984). They found
that ginsenosides elicit qualitatively and quantatively
7different responses in isolated, contracted preparations of
different blood vessels. Ginsenosides had little direct
effect on resting isolated blood vessels. Only at high
concentrations did ginsenosides contract the rabbit renal
vein. However, the extract significantly relaxed the
contracted (norepinephrine- or prostaglandin Fla -induced
contraction) rabbit pulmonary and intrapulmonary artery,
and the contracted (prostaglandin Fla- induced contraction)
canine mesenteric vein. The reason for such hetergenous
responses of different blood vessels to ginsenosides is
unknown. It was suggested that either potentiation of
contraction or relaxation of contracted blood vessels might
be mediated by interaction with endogenous vasoactive
substances (Chen et]., 1984). The simultaneous
contraction and relaxation effects may explain its biphasic
actions on blood pressure. Thus the net effect on blood
pressure and other haemodynamic parameters will reflect the
predominant vascular site of action.
Several clinical studies have shown that ginseng
can lower abnormally high blood pressure and raise
abnormally low blood pressure (Dharmananda, 1983). A
hypotenisve effect of ginseng was demonstrated in man and
was suggested to be brought about by vasodilation (Wood t
_Q1., 1964), although this study was criticised (Rh i m, 1967).
Study carried out by Schmidt et al (1978) showed that
ginseng extract could bring about reductions in systolic
blood pressure from 25 to 19 mm H9, depending on whether
8vitamins had been added to the preparation. However, the
duration of treatment was not stated in this preliminary
study.
1.2 The heart
The function of the cardiovascular system is to
convey blood which carries with it the nutrients (glucose
and oxygen) throughout the body and to render it accessible
to all tissues as well as to remove all the waste material.
The blood set in motion within a closed system of blood
vessels by the rhythmic pumping action of the muscular
heart. From the heart, blood is conveyed towards the
peripheral tissue under high blood pressure within thick-
walled arteries and it is returned from the tissues to the
heart under reduced pressure in substantially thinner-walled
veins. Both arteries and veins possess impermeable walls
but peripherally they connect with a network of vessels
called capillaries. Unlike the arteries and veins,
capillaries permit the exchange of oxygen, carbon dioxide
and other metabolites between blood and the tissues.
In man, the blood vessels are arranged in two
complementary circuits. These are the systemic circulation
which services most of the tissues of the body and the
pulmonary circulation which is distributed solely to the
lungs. The two networks are separate outside the heart but
9their cardiac connections are such that blood from one
circuit passes sequentially into the other and back again
into the first. While in the systemic circuit, blood loses
oxygen to and gains carbon dioxide from the tissues. The
reverse processes occur subsequently, when the blood is
carried through the pulmonary circulation so that it is well
oxygenated before re-entry into the systemic network.
The heart in all mammals comprises four chambers
viz two thin-walled reception chambers termed the right
atrium and the left atrium, and two thick-walled ejection
chamber named the right ventricle and the left ventricle.
The two atria are separated from each other by the
intraatrial septum. Each atrium communicates with the
ventricle by way of a valved orifice, which permits blood
flow from atrium to ventricle but not in the reverse
direction. In each cardiac cycle the atria beat
synchronously and, after a fraction of a second, the two
ventricles also contract together. From the left ventricle
blood is ejected into the systemic circulation when venous
flow returns to the right atrium. The right ventricle, on
the other hand, pumps its contents into the pulmonary
circuit which returns the blood to the left atrium. In this
manner the heart, -by the rhythmic synchronous contractions
of the two ventrciles, conveys oxygenated blood towards the
systemic capillaries and deoxygenated blood towards the
pulmonary capillaries.
The study of cardiac function in a heart totally
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isolated from the body is required when one tries to relate
properties of isolated cardiac muscle to heart function in
the intact animal. Due to the fibre arrangements within the
ventricular wall, the complexity of the spread of excitation
and the different problems related to relaxations and
filling of the heart it is impossible to derive relations
between pressure and flow throughout the cardiac cycle
directly from length tension relationships. An isolated
perfused heart preparation is indispensable for the study of
drug action on the heart. Only few drugs act solely on the
heart muscle, more often the coronary vascular bed is
influenced simultaneously and drug action cannot be
ascertained due to the complex interaction of the heart
muscle and coronary vascular system.
The need for studies on isolated perfused hearts
has already been fully recognized about a century ago. Two
different techniques to isolate the heart have evolved from
that period which are still in use today, though somewhat
modified. In 1881 Newell Martin described a functionally
isolated heart-lung preparation in an open chest dog, in
which an artificial haemodynamic resistor and a reservoir
are inserted between aorta and caval veins, while the
circulation to the body is interrupted. The isolated heart-
lung preparation of the dog served to study the intrinsic
contractile properties of the heart (Knowlton and Starling,
1914 Patterson and Starling 191A) s cardiac metabolism
(Patterson and Starling, 1913), regulation of coronary flow
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and the effects of various drugs (Markwalder and -Starling,
1913).
A second approach dated from 1895 when
Langendorff (1895) developed a perfusion techniques for the
completely isolated rat heart. He demonstrated that oxygen
can be dissolved in sufficient amounts in a saline solution
to support a heart, which is perfused in the retrograde
direction. This preparation is more advantageous to use as
there is no need to include lungs in the preparation.
Both types of isolated perfused heart
preparations have their weak points and many investigators
have tried to improve upon the original designs. Classical
Langendorff preparation requires a high coronary flow to
compensate for the row oxygen content of the saline
solution. It tends to develop oedema which results from the
low oncotic pressure of the perfusion fluid and it does not
perform any external work because the left ventricle remains
empty throughout the cardiac cycle. Mainly through the
developed oedema the mechanical properties of the muscle
change continuously and effective experimentation is
limited, depending on the limitations of the criteria for
stability. One important modification which makes the
Langendorff preparation much more practicable is the
addition of a reservoir, filled with perfusion fluid which
has a constant pressure and which is connected to both the
left atrium and the aorta through a system consisting of two
12
one-way valves. The outflow from the coronary system thus
is collected separately and usually not used for
recirculation as accumulation of substances released by the
heart may then influence the metabolic investigation. In
this way, the left ventricle ejects and performs external
work while the filling pressure and the aortic pressure can
be controlled separately.
1.3 Possible mechanisms controlling cardiac
contractility
To date, three possible mechanisms appear to be
operative in controlling the positive inotropic effects of
the cardiac muscle. These mechanisms include the activation
of calcium flux (Langer, 1965)s activation of beta-
adrenergic receptors. (Lefkowitz and Williams, 1977) and
inactivation of adenosine (a negative inotropic and
chronotropic agent which accumulates in ischaemia) receptors
(Schrader e .p.1, 1977). The details of the these mechanisms
will be discussed in the following sections.
1.3.1 calcium and contractility
It is now over one hundred year since Sidney
Ringer (1882) described the importance of calcium in the
maintenance of frog heart contractility. The interaction of
contractile proteins is regulated in the myocardium, as in
13
all types of muscle, by the amount of calcium ion-entering
the cytoplasm from extracellular and intracellular storage
sites in response to membrane depolarization._ In skeletal
muscle the calcium involved in the excitation-contraction
coupling process is released and sequestered entirely
intracellularly (Winegrad, 1970). This claim is based
primarily on the fact that the skeletal muscle cell can
continue to contract and relax when the extracellular
calcium concentration is very low (Rich and Langer, 1975).
The large skeletal sacs of the sarcoplasmic reticulum serve
in skeletal muscle as storage and release sites for calcium
(Winegrad, 1968 Endo and Nakajk i ma, 1973).
Cardiac muscle on the other hand has some
distinctive morphological and functional features that are
quite different from skeletal muscle and point to a
different mechanism involved in excitation-contraction
coupling (Shine. rte, 1971). The sarcoplasmic reticulum of
heart muscle is a simple tubular system with very small
cisternae situated just under the surface membrane and
adjacent to the transverse tubular membrane. There are no
large lateral sacs as in skeletal muscle. The force of
contraction is rapidly diminished when cardiac muscle is
perfused with a calcium free medium, suggesting that the
calcium is in rapid equilibrium with the extracellular space
(Rich and Langer, 1975). This striking illustration of the
dependence of myocardium on a source of interstitial calcium
is in marked contrast to skeletal muscle, However, the
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source of contractile-dependent calcium in the heart is
still a matter of debate (Fab i ato and Fab i ato,1977). The
controversy centred about whether all the calcium required
for contraction comes from superficial sites on the cell or
whether intracellular deposits play a role in calcium
release. However, lanthanum (La3+), which displaces
calcium from extracellular sites but does not enter the
intracellular space, effectively blocks excitation-
contraction coupling in the heart but not in skeletal
muscle. These observations seem to suggest superficial
binding sites as a major source of calcium in the heart.
It is generally accepted that inflow of calcium
across the myocardium sarcolemma accounts for most, if not
all, of the slow inward current as perfusion of isolated
hearts with calcium free medium has been shown to produce
cessation of contractility (Rich and Langer, 1975). One of
the important controlling factors in the regulation of the
rate with which calcium enters the myocardial cell surface.
There is evidence for both electrogenic and non-electrogenic
(carrier-mediated) movement of calcium (Langer, 1976).
Langer has suggested a working model for calcium entry into
the cell which incorporates these two mechanisms. A diagram
of this model is illustrated in Figure 1.2.
The model takes into account that calcium













Figure 1.2 A model for calcium movement
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in the external lamina/surface coat that are in equilibrium
with calcium in the interstitium. Calcium is proposed to
move across the membrane via two routes (Langer, 1976).
Calcium may move across the sarcolemma through pores formed
by protein subunits embedded in the lipid matrix. The
protein subunits are integral proteins which have their
carbohydrate moieties exposed to the extracellular space.
This subunit channel theory has been proposed as a possible
route for cation transport. Movement through this system
would be electrogenic.
The other calcium transport system outlined in
the Langer model for the myocardium is designated carrier in
the diagram and is based on data derived from experiments in
which sodium-calcium interaction was evaluated. It has been
suggested that an increase of sodium intracellularly might
be one of the first signals for increased calcium influx.
In this model, the movement of the carriers results in the
net transport of sodium ions outward and calcium ions inward
without a net charge transfer.
Both pore and carrier are accessible to
influences from interstitium through the surface coat. This
is an essential feature of the model and is in keeping with
experimental evidence in the myocardium. The cation
un coup l ers of excitation-contraction (e.g. La 3+, Cd 2+, Zn 2+
and Mn2+) would displace calcium from the surface coat while




Few substances have more diverse physiologic
actions in our bodies than catecholamines such as
epinephrine and norepinephrine. Catecholamines acting
through alpha-(a) and beta-() adrenergic receptors,
modulate a variety of physiological, responses in the heart.
Most importantly, catecholamines increase the rate and force
of cardiac contraction. These actions occur mainly as a
consequence of the binding of epinephrine and
norepinephrine to specific adrenergic receptors on the
plasma membrane. Whereas the effects of sympathetic nervous
stimulation on the heart have been examined for many years,
only recently has it become possible to measure directly the
properties of the receptors for catecholamines in cardiac
tissue.
1.3.2.1 Beta-adrenergic. receptors in the heart
Two distinct types of plasma membrane adrenergic
receptors appear to mediate most of the diverse effects of
the catecholamines. These were originally delineated by
Ahlquist (1948) who classified the adrenergic receptors into
two main categories: alpha and beta. There appears to be at
least two major subtypes of each of the adrenergic
receptors. Recent interest has been focused on the-
aderenergic receptor subtypes mediating inotropic and
chronotropic responses in the heart, particular in the light
of clinical implications. Both gi and receptors are
found in the hearts of certain species and are in general
coupled in a stimulating fashion to the membrane bound
adenylate cyclase. Extensive efforts have been made to
determine the properties of 3X- and g2 -receptor in the
heart. No radioligand presently available label exclusively
Brand B2 receptors; indeed, the two most commonly used
adrenergic receptor ligands C3HDdihydroalprenolol (C3HDDHA)
and[ 12513iodohydroxybenzyl-pindolol, do not distinguish
between 3i and £2 receptors (Brown et a_l- 1976). To
distinguish 3i from 32 receptors in the heart, several
groups using various selective unlabeled drugs have shown
that they have different affinities at and g2 receptors
in intact tissue. Also, competition curves of these drugs
with the radioligand are constructed and it was found that
while rat lung contained both gx and g2 receptors, rat
myocardium contained predominately, if not exclusively,
31 receptors (Barnett ill., 1978). Using similar approach
Minneman jQLl (1979) have investigated 3- receptors in the
myocardium of several species and they found that rat
myocardium contains 83% 3i and 17% 32 receptors.
1.3.2.2 Rinding studies
A large variety of hormones and neurotransmitters
exert their physiological effects by binding to specific
receptor sites, located on the external surface of the
Plasma membranes of the target cells. This binding is
followed by the activation of adenylate cyclase on the
cytoplasmic side. While the interaction between the hormone
and receptor can be easily assessed and defined by measuring
the adenylate cyclase activity, direct characterization of
receptors as discrete membrane components has been
difficult. The development of radioligand binding opened
this era of investigation. This technique involves using
radioactively labeled hormones or drugs, either agonists or
antagonists and directly measuring the binding of the
substance to its receptor.
The first successful direct binding studies of
3 -adrenergic receptors were reported in 1974 (Lefkowitz
al., 1974)» and progress has been made in the ensuing years
in applying ligand binding methodology to the study of these
receptors. Several radioligand antagonists have been widely
used to study the 3 -adrenergic receptors in a variety of
tissues. These are (-)C3H3dihydroalprenolol (C3HDDHA)5
(±)C3H3Propranolol and (±)C 125I]iodohydroxylpindolol. In
addition to these radiolabeled 3-adrenergic antagonists,
the agonist(±) isoproterenol and(± )C3HDhydroxybenzy1 iso¬
proterenol have also been used to study the 3-receptors
(Atlas££ a1., 1974; Mukherjee £t £l-, 1975; Lefkowitz and
Williams, 1977).
Beta-adrenergic receptors were first identified in
the dog myocardium using 13 HDHA (Alexander et a l., 1975).
The [3H]DHA binding sites had the characteristics expected
of interaction with -adrenergic receptors. For example,
the sites recognized catecholamines with the appropriate
stereospecific potency series. Subsequently, -adrenergic
receptors have been identified and characterised in the
myocardium of many other species including rat, cat, rabbit,
guinea pig and mouse (Chenieux-Guicherey et al., 1978 Chen
et DI., 1980). Radioligand binding has been used to
measure directly the affinity of a variety of drugs for -
receptors. Also, regulation of the number of -receptors
in the myocardium by various influence has been extensively
examined. For example, the effects of development and
ageing (Chen eta l., 1979 Baker and potter 1980) 9 guanine
nucleotides (Hegstrand et al., 1979), ischaemia (Mukherjee
at al., 1979)., and altered thyroid state (Hoffman and
Lefkowitz, 1980) have been extensively investigated.
1.3.2.3 Guanyl nucleotides an adenvlate cyclase-coupled
adrenergic receptors
Most, if not all, -adrenergic effects are
mediated by stimulation of the enzyme adenylate cyclase.
Still not understood, however, are the mechanisms by which
binding to Q-adrenergic receptors is translated into
adenylate cyclase activation i.e. how the receptor-enzyme
system is coupled. It is clear that binding to the 13-
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adrenergic receptors per se does not necessarily lead to
enzyme activation, since B-adrenergic antagonists are able
to bind to the receptor sites with very high affinity and
yet do not alter basal adenylate cyclase activity.
Therefore certain changes must accompany agonist binding in
order to elicit enzyme activation. Studies on ligand
binding and adenylate cyclase enzyme revealed the role of
guanine nucleotides in the coupling of receptor and the
activation of adenylate cyclase. This proposal is based on
the original obervations of Rodbell ett (1971) that
guanine nucleotides are required for glucagon activation of
hepatic membrane adenylate cyclase. It has subsequently
been demonstrated that stimulation of adenylate cyclase
through s-receptor require the presence of guanine
nucleotides such as guanosine triphosphate (GTP) or
nonhydrolyzable guanine nucleotide analogues such as guanyl-
5'-yl-imidodiphosphate (Lefkowitz, 1975 William and
Lefkowitz, 1977)d
Recent findings, using computer-assisted
quantitative analyses of agonist competition method,
indicate that the adrenergic receptor are capable of
existing in two discrete states having either high or low
affinity for agonists but equivalent affinity for
antagonists. Guanine nucleotides convert all the low
affinity receptors into high-affinity receptors, coincident
with hormone promoted activation of the enzyme (DeLeon at
al., 1980).
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Investigations from a number of workers on
various tissues over the past few years have led to the
proposal that the various regulatory effects of guanine
necleotides on adenylate cyclase and on receptor binding
appear to be mediated by a distinct regulatory component of
the system (Ross Gieman, 1980 Lefkowitz, 1983). This is
generally termed the guanine nucleotide regulatory protein
(N-protein), as originally proposed by Rodbel et al
(1971). Together with the hormone receptor and the
catalytic moiety of the enzyme this protein determines the
functioning of the adenylate cyclase system. A working
model (DeLean et all 1980) that incorporates these notions
into a scheme for a mechanism of adenylate cyclase
activation by hormone.agonists and guanine nucleotides is
shown in Fig. (1-3).
As depicted in Fig. (1.3), what basically seem
to be going on are several cycles of interlocking activation
and deactivation, one involving hormone receptor and N-
protein and the other involving N-protein and adenylate
cyclase. These 2 cycles are connected by the N-protein
which acts as a true coupling protein or shuttle between the
receptor cycle and the adenylate cyclase cycle. Thus the
key element is the transient formation of the high-affinity
intermediate complex HRN. GTP binds to this complex,
dissociates it to the lower-affinity form of the receptor,
















Figure 1.3 Schema for a proposed mechanism of adenylate cyclase activation by
beta-adrenergic agonists, and GTP. H= agonlst, R=B-Adrenerergic receptor
N= Nucleotide regulatory protein, C= Catvltlc moiety of adenylate cyclase.
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then activates the catalytic moiety (C). The entire process
is terminated by GTPase activity on N, which hydrolyses GTP
to GDP, ther•Hhy deactivating the enzyme. As long as hormone
or agonist remains present, the entire sequence can begin
again. Formation of HRN complex represents the crucial
coupling event. Recent findings suggest that formation of
the HRN complex is modulated by a variety of physiological
and pathophysiological circumstances and that such
modulation represents an important mechanism for the
control of tissue sensitivity to catecholamines action
(Strulorici et al, 1988; Stadel et al, 1983)
1.3.2.4 Physiologic regulation of adrenergic receptors
One of the most important insights to come from
ligand binding studies of adrenergic receptors is that the
receptors are not static entities in the plasma membranes
but rather are subject to very dynamic regulation by a
wide variety of physiological and pathophysiological
interventions. It is known that exposure of a wide variety
of cells to agonist drugs or hormones for a period of time
leads to a state of decreased responsiveness to further
stimulation by that agonist. This diminished
responsiveness, has been referred to as desensitization
tachyphylaxis or refractoriness. In experimental systems
two main types of desensitization have been delineated (Su
et al, 1976). Homologous desensitization refers to a lose
of sensitivity only to the class of agonists used to
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desensitize the tissue. In heterologous desensitization,
stimulation by one drug or hormone leads to a broad pattern
of unresponsiveness to further stimulation by a variety of
other agonists.
Two main pathways leading to such receptor
desensitization have already been identified and is outlined
in Fig. (1.4). The mechanism depicted in Fig (1.4.a)
involves down regulation or loss of receptors from the cell
surface. Exposure of the cells to an agonist leads to
uncoupling, internalization and sequestering of receptors
(Harden et all 1980 Stadel et all 1983, Strulovici et all
1983). When the agonist is removed, the receptor recycle to
the cell surface and become recoupled to the adenylate
cyclase. If agonist-induced desensitization is permitted to
continue, then at least in some cells, the internalised
receptors are destroyed, presumably by lysosomal proteases
(Harden g 1983).
3-adrenergic receptor desensitization may also
occur without receptor down regulation (Fig 1.'1.b) which
appears to be mediated largely, if not exclusively, by CAMP.
It has been demonstrated that in association with
desensitization of these cells, the 3-adrenergic receptors
become phosphorylated (Stadel et all 1983). Current evidence
suggests that the receptors may be phosphorylated by cAMP-
dependent protein kinase or alternatively by some other












































Figure 1.4 Desensitization of
G-Adrenergic Receptors by
Down regulation and Internalization (A)
and by Covalent Modification (B)
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1.3.3 Purin nucleotides and nucleosides and cardiac
function
For many years ATP was considered almost
exclusively in terms of its role as an intracellular energy
source. However, since the publication by Drury and Szent-
Gyoryi in 1929, there has been growing recognition that ATP
and related purine nucleotides and nucleosides have potent
extracellular actions on excitable membranes and that these
may be involved in physiological regulatory mechamisms (Drury
and Szen t-Gyoryi, 1929 Burn stock, 1972 R i be i ro, 1978). Of
particular interest are the proposals by Berne (1963) that
adenosine is a physiological regulator of blood flow in the
coronary circulation (Berne, 1963). This hypothesis was
based on the facts that adenosine is a potent coronary
vasodilator (Wolf and Berne, 1956) it can rapidly penetrate
the myocardial cell membrane (Jacob and Berne, 1960) its
rapidly inactivated by adenosine deaminase in the coronary
circulation to inosine (Jacob and Berne, 1960) which is
diffusible but has no dilatory action (Rubio., 1969)
its degradation products are found in the effluents of
hypoxic hearts (Berne, 1963) and adenosine itself is
recovered from the effluents of hypoxic hearts in the
presence of an adenosine deaminase inhibitor (Katori and
Berne, 1966)
According to the above hypothesis, it appears that
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adenosine is continuously produced from intracellular
nucleotide stores and released into the interstitial fluid of
the normally oxygenated heart. A decrease in-the ratio of
oxygen supply to oxygen need results in an increase in the
rate of adenosine production and release by the myocardial
cells, and the augmented interstitial fluid adenosine
concentration in turn elicits dilation of the coronary
resistance vessels. This results in an increase in coronary
blood flow which tends to restore the ratio of oxygen need to
its equilibrium value (Rubio and Berne, 1975). It has been
shown in isolated perfused hearts that either anoxia or
graded hypoxia results in an increase in adenosine production
and its release into the coronary sinus effluent (Berne,
1963 Katori and Berne, 1966 Rubio et al., 1974 Schrader et
al, 1977).
1.3.3.1 Physiological roles adenosine
Although adenosine can affect a variety of
physiological function, particular attention has been
directed over the years toward actions which might lead to
clinical applications in particularly the cardiovascular
effects of adenosine which include vasodilation, hypotension
and myocardial depression (Berne, 1963 Hollander and Webb,
1957 Hopkins, 1973 Fuiitoett 1980). Besides, the
antilipolytic, antithrombotic, and antispasmodic actions of
adenosine have also received some attention (Londos jet
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sal. ,1978 Trost and Stock, 1977)n The antiligolytic action
is due to inhibition of adipocyte adenylate cyclase by
adenosine. The antithrombotic action is due to activation
of platelet adenylate cyclase by adenosine and a resultant
inhibition of platelet aggregation. Adenosine has also
inhibitory effects on neurotransmission and on spontaneous
activity of neurons in the central nervous system (Phillis
el. al, 1977). The mechanisms are unknown but certainly
involve calcium and may involve presynaptic inhibition of
adenylate cyclase (Phillis et D1., 1979). The reversal of
the inhibitory effects of adenosine on cholinergic and
noradrenergic transmitter release by calcium ions has led to
adenosine and analogues being referred to as calcium
antagonists. Adenosine affects various other cellular
functions and the mechanisms involved in most of these
actions have not been well defined. In addition to
regulatory roles, adenosine and certain purine nucleotide
analogues can be cytotoxic agents. This action may be due
to irreversible inhibition of S-adenosyihomocysteinase
(Hershfield and Kred i ch, 1978).
1.3.3.2 Adenosine receptors
Biochemical and physiological studies revealed
that there are two types of adenosine receptors in various
tissues. Burnstock (1978) suggested a basis for
distinguishing two types of purinergic receptor according
to four criteria: relative potencies of agonists,
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competitive antagonists, changes in levels of c-AMP, and
induction of prostaglandin synthesis. According to this
classification P purinergic receptors are most sensitive
to adenosine and less sensitive to ATP, are blocked by
methylxanthines, and their occupation leads to changes in
cAMP accumulation. P2 purinergic receptors are most
sensitive to ATP, less sensitive to adenosine and are
blocked by quinidine, 2-substituted imidazolines and apamin,
and their occupation leads to production of prostaglandin.
It has now been recognized that there are not one
but at least two classes of extracellular P, receptors
involved in the action of adenosine (tondos and Wolff,
1977). One is high-affinity receptor inhibitory to
adenylate cyclase which. is present in adipocytes, heart and
brain cells (Van Calker et al., 1979 Londos et al., 1980),j
affinity constants for adenosine and analogues are in the
low nanomolar range. These have been termed the A
Londos et al. (1980)m The other class of P, receptors is
more ubiquitous in occurence and is a low-affinity receptor
stimulatory to adenylate cyclase, affinity constants for
adenosine and its analogues in the low micromolar range
(Daly at p1, 1981). Virtually all adenylate cyclases appear
to have a third adenosine sensitive site associates with
them, namely the inhibitory P site. This is not a receptor
site but rather an intracellular site, perhaps directly
associated with the catalytic subunit of the enzymes (Wolff
receptors by Van Calker et al (1979) and R, receptors by
et al., 1978 Premont, 1979). The affinity constantion
the low to high micromolar range. The physiological
significance of this site is unknown, since it seems
unlikely that free adenosine levels in intact cells ever
reach high micromolar concentrations.
1.3.3.3 Binding studies on adenosine receptors
During the past decades a wide range of adenosine
analogues have been developed to elucidate the nature of
adenosine receptors involved in various physiological
functions. In addition, relatively specific agents which
inhibit either high-affinity uptake of adenosine or
metabolism by adenosine deaminase or adenosine kinase have
been developed. The development of these radioligands
provide means for studying binding characteristics of
adenosine receptors, the receptors subtypes and the tissue
distribution of subtypes.
Early studies on adenosine receptors had utilized
radioactive adenosine itself and adenosine was found to bind
to a variety of sites, both in soluble and membrane
fractions (Davies DI., 1980). Binding sites for at
show characteristics entirely consonant with those expected
of either the A,- or A2 -adenosine receptors (Dutta and
adenosine in membranes from fat cell or arteries did not
for adenosine and analogues for this inhibitory site are in
Mustafa, 1980)- Theophylline was virtually inactive as an
antagonist in either fat cells or arterial membranes.
However, binding sites for adenosine in guinea pig cerebral
cortical membranes appeared in many respects to correspond
to adenosine receptors and both 2-chloroadenosine and
theophylline were potent antagonists of the binding (Newman
.Ql- 1981)- More than one class of binding site appeared
to be present in the guinea pig since theophylline only
partially antagonized the specific binding of adenosine. In
contrast, in rat brain membranes, using similar assay
conditions, theophylline was only a very weak inhibitor of
adenosine specific binding, requiring a concentration of
about 2 mM for 50% displacement (Schroder nI- 1979).
It appeared likely that the most satisfactory
ligand for the adenosine receptor would be an analogue which
was not subject to metabolism by adenosine deaminase or to
high-affinity transport systems and which had an affinity
for adenosine receptors greater than adenosine itself. In
1980 several workers reported the development of protocols
for the characterization and investigation of binding of
radioactive adenosine analogues to brain membranes. These
ligands were 2-chloroQ3HDadenosine (Williams and Risley,
1980) N6 -cyclohexy1[3 HHadenosine and L~N6-C 3 HllPheny 1 i so-
propy1adenosine (Bruns et a 1 1980)- The profile of
antagonism by adenosine analogues of binding of these
ligands to brain membranes were consonant with interaction
primarily at an A, -adenosine receptor. In these studies,
pretreatmemt of membrane with adenosine deaminase during
binding assays appeared necessary to remove endogenous
adenosine and thereby prevent its competitive binding to
receptors (Trost and Schwabe, 1980).
Densities of specific binding sites for the
various adenosine ligands have been found to be higher in
brain than in other tissues. In rat brain, the densities of
specific binding sites for N6-cyclohexy1C3HUadenosine were
about 9 pmol per gram wet weight of brain, while being about
2 pmol per gram wet weight in testes and less than 0-3 pmol
per gram wet weight in heart, lung, kidney, adrenal,
stomach, small intestine, pancreas, thyroid (Murphy and
Snyder, 1981). Regional distribution of binding sites for
2-chloroC 3 HDadenosine in brain was relatively uniform
(William££ Hi-, 1980). There was only about 2-fold
difference between the lower values in the cortex,
hypothalamus, spinal cord, medulla and pons and the higher
values detected in the thalamus, cerebellum and hippocampus.
Specific binding sites for 2-chloroC3HDadenosine were about
3-fold lower in testes than in brain while being fully 20-
fold lower in liver, kidney and heart (William££ xil-,
1980).
I -4 Alms Ql the present study
Complicated and seemingly conflicting effect of
ginseng saponins on the isolated perfused rat hearts was
reported (Kim££ jaLL-, 19805 1982)- The effect of ginseng
total saponins, ginsenosides R and R on the
contractility of isolated rat hearts was investigated by Kim
Ql (1980)- It was found that ginseng total saponins
exhibited a slight increase in contractility while
ginsenoside Rl markedly increased the contractile force in
a dose-dependent manner. However, ginsenoside R did not
increase the contractile force, but it prevented spontaneous
decrease of the contractility of the heart. Mixture of the
same dose of ginsenoside RL and Rp showed a slight increase
in contractility and its effect was similar to that obtained
by ginseng total saponins. Pretreatment with propranolol
abolished the positive inotropic effect of ginsenoside RL
In a later study, however, in contrast with their previous
findings, Kim n! (1982) reported a positive inotropic
action of ginsenoside R on the isolated rat hearts.
In view of the above inconsistent findings and
the lack of knowledge concerning the mode of action of
ginseng saponins on the contractility of isolated rat
hearts, the present study was undertaken to investigate the
effect of ginseng total saponins on the cardiac performance
in the rat, and to attempt to elucidate its mechanism of
action.
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In the first part of the study, the inotropic
response produced by ginseng total saponins was investigated
using a Langendorff isolated perfused heart preparation.
Since its introduction by Langendorff the isolated perfused
heart has been frequently used as an experimental model in
pharmacology, biochemistry and physiology. The main
advantages of the method are that the heart can be kept
beating for hours, that it is easily accessible for a
variety of measurements and that chemically defined media
can be used for perfusion.
To complement the physiological studies, bio-
chemical studies were also carried out. The biochemical
studies include the effects of ginseng total saponins on
calcium transport in ventricular slices and sarcoplasmic
reticulum, -adrenergic and adenosine receptor by direct
binding assays using labeled adrenergic and adenosine
analogue. It is believed that this approach would provide
valuable insight into the mode of action of ginseng total
saponins on the contractility at the molecular level.
Materials
Method
Chapter 2 MATERIALS AND METHODS
2.1 Materials
45
Calcium (40 mCimg calcium),(-)[ 3H3dihydro-
alprenolol 077 Cimmol), (-)N6C3H]Phenylisopropyladenosine
(42 Cimmol), (-)[3H3adenosine (45 Cimmol) were purchased
from the Radiochemical Centre, Amersham, Bucks., U.K.
Adenosine, theophylline, caffeine,(+)-
isoproterenol HC1» (±)-propranoiol HC1 (-)norepinephrine
HC1 N6-Phenylisopropyladenosine, adenosine deaminase (calf
intestinal mucosa) were purchased from Si9ma Chemical Co.,
St. Louis, U-S-A- Atenolol was purchased from Imperial
Chemical Industries Limited, Macclesfield, U.K. Metoprolol
was obtained from Hassle, Sweden.
Dried white ginseng roots from Kirin, China was
purchased from the herbal store in Hong Kong. Thin layer
chromatography precoated plates, silica gel 60GF were254
obtained from Merck, Darmstadt, Germany.
All other reagents and chemical were of
analytical grade.
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2.2 Photochemistry ginseng of
2.2.1 Extraction ginseng total saponins of
Ginseng total saponins was extracted according to
the procedure developed by Shibata e as outlined in
Figure 2.1.
About 200 9 of white Kirin ginseng root was
sliced into thin pieces. The material was macerated in 1
litre of methanol overnight, refluxed at 60°C for 4 hours
and the extract collected. The reflux procedure was repeated
twice using fresh methanol. The methanolic extracts were
combined, filtered, and evaporated to dryness in a rotary
evaporator under reduced pressure. The dried extract was
suspended in water. The aqueous suspension was then
defatted three times with diethyl ether. The aqueous phase
was then extracted three times with water-saturated n-
butanol. The combined n-butanol extract was washed once
with n-butanol saturated water. The final n-butanol extract
was evaporated to dryness to obtain the ginseng total
saponins and this ginseng extract was used throughout the
study. The composition of this extract was determined by
thin layer chromatography.
Figure 2.1 Extraction of ginseng total saponins
Ginseng




















Aqueous Layer n-Butanol lavar






Aqueous Extract n-Butanol Extract (Ginseng total saponins
-2.2 Thin layer chromatography q£ ginseng total
Individual components in the ginseng total
saponins were identified by thin layer chromatography using
authentic ginseng saponins as standards- Plastic precoated
thin layer chromatography plate, silica gel 60F, was254
used for the analysis. Two solvent systems, n-butanol:
ethyl acetate: water (4:1:5) and chloroform: methanol:
water (65:35:10) were employed according to Shibata _£t al,
(1965)- Individual ginseng saponins was detected by
spraying with 10% H2S04 and heated for 15 min at 110°C and
quantitative analysis was achieved by High Speed TLC scanner
(Schimadza, C5-920)-
2-3 i anqendorff isolated perfused jzot heart
preparation
2-3-1 Preparation of the heart
Male Sprague-Dawley rats weighing 290-350 9 were
employed throughout the study. The animals were fed with
Purina Lab chow ad libitum and had free access to water.
The rat was sacrified by cervical dislocation and the
abdominal cavity opened by making a transverse incision with
the scissors. The diaphragm was transected and lateral
incision were made along both side of the rib cage. The
anterior chest wall was folded back. The pericardium and
other filamentous tissues were pulled away from the heart.
The heart was picked up and the lungs and other chest
content pushed toward the back. The heart was rapidly
excised, immediately suspended in an ice-cold oxygenated
Krebs-Henseleit solution and was squeezed several times to
remove as much blood as possible. Using a fine-tipped
forcep, the heart was picked up by the aorta and the
connective tissue, thymus, or lung that may have been
removed with the heart was pulled away. The aorta was cut
below the point where it divided.
2.3.2 perfusion o£ ihe heart
2-3.2.1 Perfusion mediun
Modified Krebs-Henseleit bicarbonate medium, pH
7.4, equilibrated with 95% 02: 5% C02 at 37°C was used in
the experiment. Oxygenation was accomplished by bubbling
gas through the perfusate. Final concentrations of the
salts in this medium( in mM) were: NaCl 118.15 KC1 4-75
M9S04-7H20j 1.25 KH2P04 1-25 NaHC03 255 glucose, 11-15
CaCl2.2H20» 1.25.
2-3-2-2 Perfusion techniques
A diagram of the apparatus was shown in Fi9ure
2-2- The cut aortic stump was secured with a ligature to a
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grooved cannula for retrograde perfusion of the coronary
circulation- Care was taken to ensure that no air bubbles
entered the aorta- Perfusion was begun by delivering
perfusate to the heart either from a peristaltic pump
(constant flow model) or a washout reservoir (constant
pressure model)- Therefore, the heart was perfused either
at a constant flow rate (10-12 mlmin, 40-60 mm H9) or under
a constant pressure (5-8 mlmin, 60-80 mm H9). The heart
was paced by means of a stimulator (Grass model SD) at a
rate of 300 beatsmin so as to eliminate the effects of
individual variations in heart rates on coronary flow and
left ventricular pressure- Thus, after mounting the heart
on the aortic cannula, thin platinum electrodes were
inserted into the apex of the right atrium and base of the
left ventricle-
Left ventricular pressure (systolic- diastolic)
was used as an index of contractile function. It was
monitored throughout the experiment using a catheter pushed
through the apex of the left ventricle and attached via a
fluid-filled catheter to a pressure transducer (Statham
model FT3). Alterations in coronary flow was measured by a
drop counter while change in perfusion pressure was
monitored by means of a pressure transducer- Si9nals from
the transducer were recorded on a 4-channel physiograph
(Model MK-IV Narco Biosystems).
The heart was stabilized for at least 20 min
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before any injections of drugs were made. Cumulative ginseng
total saponins dose response curve was produced by injection
of the ginseng extracts into the perfusion medium through
the rubber cap which was situated at a sidearm of the
aortic (Figure 2.2). Ginseng total saponins were injected
in increasing dose from 10- 1000 ug per isolated heart.
The volumes of the ginseng extract injected were kept
between 0.025 ml to 0.1 ml and this produced only a small
injection artifact which can be well separated from the drug
response.
2.4 45Calcium uptake
2.4.1 45Calcium uptakle hy ventricular slices i.tro
Male Sprague-Dawley rats weighing about 350 9
were killed by cervical dislocation. The heart was removed
and slices of ventricular tissue of 0.3 mm thick were
prepared using a tissue chopper [McIlwain]. 45 Calcium
uptake (1.3 mM, specific activity, 1.16 uC i/umo l) was
performed in a final volume of 1 ml of Krebs-Ringer
phosphate buffer (composition in mM: NaC1, 144.6 KC1, 5.8
M9S04.7H 20, 1.43 CaC 12- 2H 20, 1.3; glucose, 10 NaH2 PO4.2H 20,
10) PH 7.4,. Drugs, including ginseng extract were added
as an aqueous solution as indicated in the Results. After
30 min of incubation at 370C in an atmosphere of 95% 02- 5%
C02, the tissue was then washed with 2 ml of ice-cold Krebs-
Ringer phosphate buffer and solubilized with 1 ml of 2M
NaOH- Following solubi1ization, 500 ul aliquot was then
withdrawn and mixed with 7 ml of Triton-toluene based
scintillation fluid (0.4% PPO 0.04% P0P0P in 2 volumes of
toluene and 1 volume of Triton X-100) and the radioactivity
incorporated was counted in a Beckman LS-7000 liquid
scintillation counter.
2-4-2 Preparation q£ sarcoplasmic reticulum
The procedure was as described by Bers (Bers,
1979) and outlined in Fi9ure 2.3. All preparatory steps
were performed at 4°C- Hearts from six male Sprague-Dawley
rats were pooled, and the ventricular portions (5-6 9) was
minced in 10 volumes of homogenizing buffer consisting of
0.3M sucrose, 2mM ascorbic acid, 20 mM Tris-HCl PH 7.2 and
homogenised with a Polytron homogenizer (Kinematica PCU 2)
at setting 7 for 15 sec. The homogenate was passed through
a single layer of cheesecloth to remove cell debris, and the
filtrate was centrifuged at 12000 xg for 20 min in a Sorval
RC 5 refrigerated centrifuge. The pellet was discarded and
the supernatant was recentrifuged at 40000 xg for 90 min.
The final pellet was resuspended in Krebs-Ringer phosphate
buffer using a Teflon pestle, giving a final concentration
of approximately 1 mg of protein per ml.
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2-4-3. asCqlCiurn uptake by sarcaplasmic reticulum
The assay method for 45calcium uptake by
sarcoplasmic reticulum was similar to that described for
ventricular slices except that the incubations were carried
out in Eppendorff microcentrifuge tubes. 45 Calcium uptake
(1-3 m(15 specific activity, 1-16 uCiumol) was performed in
a final volume of 1 ml of Krebs-Ringer phosphate buffer.
Ginseng extract at various concentrations were added as
indicated in the Results. Incubation was terminated by
centrifugation using an Eppendorff microcentrifuge (Model
5414) for 2 min. Following the removal of the supernatant
and washing with 1 ml of ice-cold incubation medium, the
pellet was dissolved in 1 ml of 2M NaOH and 500 ul aliquot
was withdrawn for radioactivity determination.
2-5 Plasma membrane preparation
For all binding studies, the membrane fraction
was prepared essentially as described by Williams and
Lefkowitz (1977) and outlined in Figure 2-4- All
preparatory steps were performed at 0-4 C- Cardiac membranes
for binding studies were prepared by mincing ventricles in
20 volumes of cold homogenizing buffer containing 0-25 M
sucrose, 1mM M9C12 5mM Tris-HCl» PH 7-4- The mince was
then homogenised with a Polytron homogenizer (Kinematica
PCU 2) at a setting of 7 for 15 sec, and diluted to 1:30
Figure 2.4 Plasma membrane preparation
MinrArl uon-r irloo
r 20 volume of
Homogenization..._ Ai
(polytron: setting-7, timer: 15sec)
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(vv) with homogenizing buffer- The homogenate was filtered
through a single layer of cheesecloth and centrifuged at 480
xg for 10 min. in a Sorval RC5 refrigerated centriguge. The
pellet, containing connective tissue and high density
debris, was discarded, and the supernatant was centrifuged
at 30j000 xg for 10 min. The pellet was resuspended in 20
volumes of ice-cold incubation buffer (10 mM M9C12j 50 mM
Tris-HCl, PH 7-4) and centrifuged (30,000 xg, 10 min) twice.
The final washed pellet was resuspended with incubation
buffer to give a protein concentration of 2-4 mg ml.
2-6 Rinding studies
2-6-1 (-)f3 HIDihydroalPrenolol(f3H1DHA) binding
The C 3 HUDHA binding studies were carried out
according to the method reported by Williams and Lefkowitz,
(1977)- The reaction mixture consisted of 100 ul of
membrane suspension (200-400 ug of membrane protein), 50 ul
of 20 nM [3H3DHA in a final volume of 200 ul. Whenever
required, (+)-propranolol (10 M to 10 M)»(-)-
isoprotereno1o1 (10 6 M to 10 M) or ginseng total extract
(0-5-2500 ugml) was added. In some experiments, as
indicated in the text, cardiac membrane was pretreated with
the ginseng extract (0-5-2500 ugml) for 5 or 10 min at 37°C
The mixture was incubated at 37 C for 10 min with
continuous shaking. The binding reaction was terminated by
dilution with 1 ml of cold incubation buffer followed by
rapid vacuum filtration of the entire mixture through
Whatman GFC 9lass fiber filter (presoaked in incubation
buffer). The filter was immmediately washed twice with 5 ml
of cold incubation buffer, placed into scintillation vials,
oven dried, and counted in? ml of Triton-toluene based
scintillation fluid. Radioactivity retained by the filter
in the absence of membrane was also performed to obtain the
background counts i.e. the filter blank.
Non-specific binding to membranes was determined
by measuring the amount of radioactivity retained on the
filter when incubation was performed in the presence of 10
uM C+)-propranolol. Specific binding was determined by
substracting the non-specific binding from the total binding
obtained in the absence of the antagonist.
2-6-2 C-)r3H1Phenylisopropyladenosine ([3H1PIA) md
c-)r3Hiadenosine binding cdrdidc membranes
Cardiac membranes for C3HDPIA and C 3 HUcidenosine
binding studies were prepared essentially as described in
section 2-6-1- The reaction mixture consisted of 100 ul of
membrane suspension (200-400 ug of membrane protein),
]adenosine in a final volume of 200 ul.




(10 to 10 M) or ginseng total saponins (0-5-2500 ugml)
was added as aqueous solution in a volume of 50 ul. The
assay method was the same as the [3H3DHA binding as
described in section 2-6-1-
In some experiments prior to the binding assay,
the membrane suspension was pretreated with adenosine
deaminase at two different concentrations i.e. 1 mg and 5 mg
of enzymeml of membrane protein. The mixture was allowed
to incubate at 37°C for 30 min with shaking and centrifuged
at 30j000 xg for 10 min. The pellet was washed twice with
incubation buffer and finally resuspeneded in incubation
buffer, giving a concentration of approximately 2-4 mg of
proteinml. Protocol and procedures for the binding assay
was exactly the same as described in section 2-6-1-
Specific C3H3adenosine or C3HHPIA binding is
defined as the difference between total binding in the
absence of adenosine or phenylisopropyladenosine
respectively, and the non-specific binding found in the
presence of 10 uM of phenylisopropyladenosine or adenosine.
2.7 Protein deterfPination
Protein was determined by the method of Lowry££
J31- (1951) using bovine serum albumin as standard. Briefly,
to each 100 ul of sample, 3 ml of copper reagent (2% CuSO.
7H2 0: 4% K-Na-tartrate: 3% Na CO,) was added. After
mixing, the sample was allowed to standard at room
temperature for 10 min and 0-3 ml of diluted Folin reagent
(151 dilution) was then added and followed by immediately
mixing. After standing for 45 min at room temperature, the
absorbance at 660 nh was measured on a digital




3.1 Characterization of total ginseng saponins
The yield of the total ginseng saponins was 2.8%.
The ginsenosides present in the extract were separated and
identified by thin layer chromatography through the
procedures as described in Method. Two solvent systems, n-
butanol: ethyl: acetate: water (4:1:5) and chloroform:
methanol: water (65:35:10) were used as the developing
solvent. Authentic ginseng saponins were used as standards
and the results were shown in Figure 3.1. It was observed
that better resolution was achieved by the n-butanol system.
Ginsenosides Rb, Rc, Rd, Re, Rg were identified in the
extract and that the sample contained higher proportion
of Rb Re and Rg than other ginsenos i des (Table 3.1)
Effect of ginseng on isolated perfused rat heart3.2
contractility
Heart perfusion at constant pressure3.2.1
Hearts were perfused at a constant pressure of
60-80 mm H9 and with a flow rate of 5-8 ml/min as described
in Method. Left ventricular pressure was used as an index
of cardiac contractility and the effect of ginseng on
contractile force of the Langendorff preparations was
Fi9ure 3-1 Thin layer chromatography pf ginseng total






































Identification of individual ginsenosides was made by
means of the thin layer chromatography using the lower layer
of a mixture of n-butanol: ethyl acetate: water (4: 1 :5)
as a development solvent and quantitative analysis of the
identified ginsenosides was achieved by means of a High
Speed thin layer chromatography scanner.
investigated. Ginseng total saponins (0-3-2-8 mgK9)
increased cardiac contractility in a dose-dependent manner,
and a cumulative dose-response curve relating dose of
ginseng to change in left ventricular pressure was plotted
in Figure 3-2- A significant increment in left ventricular
pressure was obtained with ginseng total saponins at
concentrations of 0-3-1-0 mgK9- It was reported that a
coronary flow of about 20% of cardiac output (183
mlminK9) is required for the maintenance of proper cardiac
performance in rat (Koo et 01, 1979). For normal
functioning of the heart, a coronary flow of about 11 mlmin
is essential (for a 0-3 K9 rat). Therefore ischaemia was
induced when the isolated heart was perfused under the
constant pressure model (60-80 mm H9 5-8 mlmin). In
addition, hypoxia also occurred with this preparation as the
oxygen-carrying capacity was significantly reduced in the
isolated perfused heart due to the absence of haemoglobin.
The possibility that the positive inotropic
effect of ginseng total saponins may be mediated via the
activation of 3 -adrenergic receptors was tested by infusion
of the preparation with selective 3 -blocker such as
metoprolol and atenolol. The heart was infused with
increasing concentrations of metoprolol for 30 min after the
dose-response curve was obtained and the results were shown
in Table 3-2- Cumulative dose-response curves were obtained
both in the control and metoprolol groups (Fi9ure 3-3)- The
positive inotropic responsiveness of the left ventricle to
Fi9ure 3-2 Cumulative dose response curve relating
dose of ginseng total saponin to change
in left ventricular pressure
Values are expressed as means+ S-E-M-
with the number of isolated hearts in
each group given in parentheses.
Statistical analysis was performed by
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Hearts were perfused with oxygenated Krebs Henseleit
medium at a flow rate of 58 mlmin and a perfusion pressure
of 60-80 mm H9 as described in Method., In metoproioi
perfusion experiments, hearts were perfused with increasing
concentrations of metoproioi, final concentration being
1-76 x 10-6M and 10~SM for 30 min after the first dose
response curve was obtained and ginseng total saponins was
administered as described in Method-
Values are expressed as means+ S-E-M- with the
number of isolated hearts in each group given in
parentheses. Statistical analysis was performed by
Students• t-test: P0-01s and p 0-001 compared with
the control.
Fi9ure 3-d Effect of ginseng total saponins on left
ventricular pressure in the presence and
absence of metoprolol
Values are expressed as means .iS.E-M
with the number of isolated hearts in
each group- given in parentheses.
Statistical analysis was performed by
Students' t-test: Dtd_ m nnri
•P0-001 compared with the control,
contro1
perfusion with 1.76 x 10 h metoprolol
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9inseng total saponins after metoprolol infusion as measured
by change in left ventricular pressure were less marked than
in the control(Figure 3.4) however, the dose-response curve
did not shift to the right after blockade with selective£-
blockers. The above experiments were repeated with another
adrenergic receptor antagonist, atenolol, and similar
findings were obtained as shown in Table 3.3 Figure 3-5-
and Figure 3-6-
3-2-2 Heqrt perfusion cat constant flow
Using a different model of perfusion, the effect
of ginseng total saponins on left ventricular pressure was
studied. Hearts were perfused at a constant flow rate of
10-12 mlmin, with a perfusion pressure of 40-60 mm H9 and
the results were shown in Table 3-4- No substantial
increase in left ventricular pressure was observed with
increasing concentration of ginseng total saponins and the
change at the higher doses of ginseng extract was
statistically not significant. This was in contrast with
the finding obtained in the constant pressure model where
significant increase in contractility was observed when
ginseng total saponins (0-3-1-0 mgK9) was administered. A
comparasion of the two models on the effect of ginseng total
saponins on left ventricular pressure was made and depicted
in Figure 3-7 and 3-8 it is clear that the order of
increase in left ventricular pressure differed significantly
in the two models.
Figure 3.4 Physiograph showing the effect of
ginseng total saponins on the left
ventricular pressure in the presence and
absence of metoprolol
Chart speed= 20 sec/cm
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Hearts were perfused as described in Table 3-2 and
atenolol perfusion was performed essentially the same as
described for metoprolol.
Values are expressed as means+ S-E-M- with the number
of isolated hearts in each group given in parentheses.
Statistical analysis was performed by Students' t-
test: P 0-01 and P0-001 compared with control.
ventricuiar pressure in the presence and
absence of atenolol
Figure 3-5 Physiograph showing the effect of
ginseng total saponins on the left
ventricular pressure in the presence and
absence of atenolol
Chart speed= 20 sec/cm
40 mm H9= 1 cm
CONTORL
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Figure 3.6 Effect of ginseng total saponins on the
left ventricular pressure in the
presence and absence of atenolol
Values are expressed as means± S.E.M.
with the number pf isolated hearts in
each group given in parentheses.
Statistical analysis was performed by
Students' t-test:* P0.01 and
**p0.001 compared with the control.
• control
A perfusion with 10 -6M atenolo
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Table 3.4 Effect .of ginseng total saponins left





















Hearts were perfused with oxygenated Krebs Henseleit
medium at a flow rate of 10-12 mlmin and a perfusion
pressure of 40-60mm H9 as described in Method. Values are
expressed as means± S-E-M- with number of isolated hearts
in each group given in parentheses. Statistical analysis
was performed by Students's t-test and the results were
fni inH to hp qf-irnl 1 v not siQnificant.
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Physiograph comparing the effect ofFigure 3.7
ginseng on left ventricular pressure
under constant flow/pressure model
Chart speed= 20 sec/cm
10 mm H9= 1 cm
Constant Pressure Model
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Fi9ure B-8 Comparison of effect of ginseng total
saponins on left ventricular pressure
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3.3 Fffect .of 9insenq total saponins £LD 5 calcium
uptqke io ventricular si ices and sarcoplasmic
reticulum
The presence of extracellular calcium is
necessary for contraction in the cardiac muscle as perfusion
of isolated hearts with calcium free medium has been shown
to produce cessation of contractility (Fabiato and Fabiato,
1977)- Since the physiological studies showed that ginseng
total saponins had a positive inotropic action on isolated
perfused rat heart, studies on the effect of ginseng total
saponins on 45 calcium uptake in ventricular slices and
sarcoplasmic reticulum were performed to see if ginseng
total saponins may exert its action by influencing calcium
fluxes in these two preparations In vitro.
Data with certain variability were obtained in
the study of the effect of ginseng total saponins on
45calcium uptake in ventricular slices (Table 3-5)-
Stimulatory action was seen at most doses of ginseng total
saponins though a dose—dependent stimulation was not
observed- Flowever, no substantial difference in 45 calcium
uptake was observed when the experiment was carried out
using sarcoplasmic reticulum (Table 3-6)- Also, the data
varied less marked when compared to that obtained with
ventricular si ices.
Table 3-5 Fffeet J2f ginseng tPtqj saponins iia 5calcium























Ventricular slices of 0.33 mm thick were
prepared using a tissue chopper. Uptake of 45Calcium (1.3 mM,
specific activity, 1-16 uCi'umol) was performed in a final
volume of 1 ml of Krebs-Ringer phosphate buffer containing 50
ul of ginseng extract at various concentrations as indicated.
After 30 min of incubation at 37°C in an atmosphere of 95% 02
-5% C02» the tissue was then washed with 2 ml of ice-cold
Krebs-Ringer phosphate and solubilized with 1 ml of 2M NaOH-
Following solubilization, 500 ul aliquot was withdrawn for
radioactivity determination.
Each value represents the mean+S-D- of
triplicate determinations and results were expressed as
percentage of 45calcium uptake in the absence of added ginseng
total saponins (the control) which was found to be 1-39±
0-12 pmolmg protein.
Statistical analysis was performed by
Student's t-test: P 0.01 and p 0-001 compared with
uptake in the control.
Table 3-6 Fffect if 9inggpg fafal saponins in 5calcium






















100 ul of membrane suspension (200-400 ug membrane
protein) was incubated at 37°C for 10 min with 45calcium (1.3
mM, specific activity, 1.16 uCiumol) in 1 ml of Krebs-Ringer
phosphate buffer. Ginseng total saponins at various
concentrations were added in a volume of 50 ul as indicated.
Incubation was terminated by centrifugation in an Eppendorf
microcentrifuge. Following the removal of the supernatant and
washing with 1 ml of ice-cold incubation medium, the pellet was
dissolved in 1 ml of 2M NaOH and 500 ul was withdrawn for
radioactivity determination.
Each value represents the mean± S-D. of triplicate
determinations and results were expressed as percentage of
5calcium uptake in the absence of added ginseng. Calcium
uptake in the absence of added ginseng (the control) which was
found to be 4-0± 0-02 pmolmg protein.
Statistical analysis was performed by Students' t-
test and the results were statistically not significant when
compared with the control.
3.4 Effect .Of 9insenq onr3HIdihvdroa 1 preriolo 1(r3HrnHA)
binding
An increase in contractile force of the
myocardium is the most consistently reported response to g-
adrenergic stimulation (Alexander££ jsl-, 1975)- Successful
use of C 3 HUDHA to label binding sites derived from rat
myocardium that have the characteristics expected of£-
adrenergic receptors have been reported (Lefkowitz and
Williams, 1977). As data obtained from physiological studies
(Fi9ures 3-3 and 3-6 and Tables 3-2 and 3-3-) suggests that
ginseng total saponins does not seem to exert its inotropic
action by interacting with cardiac g -adrenergic receptors,
radioreceptor assay was performed to ascertain the
Physiological study using C3HHDHA-
Table 3-7 shows the effect of ginseng total
saponins on C3H3DHA binding- Significant inhibition of
binding was seen only at very high doses of ginseng extract
(1600-2500 ugml) and this may be due to the detergent
effect of ginseng total saponins- As this experiment was
performed in the presence of ginseng total saponins and
C3HDDHA» it is possible that the presence of [3H]DHA may
have some protective action on the adrenergic receptor
andor its micro-environment as similiar phenomenon has been
shown to occur in other radioreceptor assays (Hiller and




























The reaction mixture consisted of 100 ul of
membrane suspension (200-400 ug protein), 50 ul of C3HDDHA
(20 n(1) in a final volume of 200 ul- Ginseng total saponins
at various concentrations were added as indicated in the
table. The mixture was incubated at 37°C for 10 min with
continous shaking. Reaction was terminated by dilution with
1 ml of cold incubation buffer containing 10 mM h9Cl2 and
50mM Tris-HCl PH 7-4 followed by rapid vacuum filtration
through GFC filter. The filter was immediately washed twice
with 5 ml of ice-cold incubation buffer, oven dried and
radioactivity determined.
Total binding was measured in the absence of
propranolol, and non-specific binding was taken as_5the
C3H3DHA bound in the presence of the antagonist (10 5M).
Specific binding was obtained by substracting the non¬
specific binding from the total binding. Each value
represents the mean± S-D- of three determinations and
results were expressed as specific C3H3DHA bound (fmolmg
protein). Statistical analysis was performed by Students' t-
test: p 0-01 and p 0-001 compared with the control.
Simon, 1976) and it was decided to investigate the effect of
ginseng preincubation on C3H3DHA binding.
Table 3.8 shows the effect of preincubation of
cardiac membranes with various concentrations of ginseng
total saponins on C3H3DHA binding. Five minute preincubation
of membrane had no significant effect on C3HDDHA binding at
low doses of ginseng extract while substantial inhibition of
binding was observed at extremely high doses (500 ugml).
The detergent effect of ginseng total saponins may be the
reason. A rather different pattern was obtained when the
time of incubation was prolonged. Ten-minute preincubation
of the membranes with ginseng total saponins resulted in
inhibition of C3H3DHA binding at all doses of ginseng but
significant inhibition was observed at extremely high doses
(500 ugml) only. Also, the amount of specific C3H3DHA
bound was much reduced in all cases. The reason is not
clear. Though the detergent effect of ginseng total
saponins may be a possible explanation, it is unlikely
this can explain the results fully.
3-5 Fffeet of ginseng total saponins and purinergic-
reiated compounds on c3Hlphenyl jtSQPropy1adenosine
(r~3H1PT A) binding in cardiac membrane
Adenosine is known to exert various actions on
the myocardium (Buckley, 1970). The cardiac effects of
Table 3. 8
Effect flf Qinseng total saponins on [H]dihvdro-

















































Prior to incubation with [3HDDHAj the membrane was
preincubated with various concentrations of ginseng extract
for 10 min at 37°C- The binding assay was carried out as
described in Table 3-7-
Values shown are means± S-D- of triplicate
determinations and expressed as specific C3HDDHA bound
(fmolmg protein). Statistical analysis was performed by
Students' t-test: P 0-01 and p 0-001 compared with
the control.
adenosine include negative inotropic (Schrader££ cil., 1977)
and chronotropic actions (Stafford, 1966). The possibility
that ginseng total saponins may exert its action on
adenosine receptors which may account for the observed
positive inotropic action was examined. The presence of
binding sites for [3HDPIA which display the characteristics
of adenosine receptors have been demonstrated in plasma
membrane of rat fat cells and synaptic membranes (Trost and
Schwabe, 1980). To determine if [3HDPIA is also a suitable
ligand to study adenosine receptors in cardiac membranes
and to study the possible influence of ginseng total
saponins on adenosine receptors, the effect of ginseng
extract and various purinergic-related compounds on C 3 HDPIA
binding was investigated.
No significant displacement of [3HDPIA bound was
observed when C 3HDPIA was incubated with rat cardiac
membranes in the presence of increasing concentrations of
unlabeled PIA (Table 3-9). Similarly, no substantial
reduction on C 3HDPIA binding was seen with various
concentrations of adenosine or its degradative product,
inosine. Theophylline, which has been classified as
antagonist for p site adenosine receptors (Williams and
Risley, 1980)? also did not compete for the binding sites of
— A
C 3HDPIA at concentrations up to 10 M in a manner which
parallels its known activity in brain cells (Trost and
Schwabe, 1980). Furthermore, ginseng total saponins had no
effect on C 3 HDP IA binding. Moreover, the amount of
Table 3.9 Fffeet .of ginseng total saponins and purinerqic-
reiated compounds on totd1c3Hipheny1isopropy1-
adenosine binding in cardiac membranes
pretreated with adenosine deaminase
Cardiac plasma membranes was prepared as described
in Method. After the last centrifu9ation, the membrane was
resuspended in cold incubation buffer (10 mM M9C12 and 50 mM
Tris-HCl PH 7-4) to give a final protein concentration 2-4
mgml and incubated with adenosine deaminase (1 mg and 5
mgml) for 30 min at 37°C with continuous shaking. At the
end of incubation, the mixture was centrifuged at 30000 xg
for 10 min. In order to remove traces of adenosine deaminase
which might be associated with the membrane, the pellet was
washed twice with 30 volumes of incubation buffer and
centrifuged before resuspension in incubation buffer.
The reaction mixture consisted of 100 ul of
membrane suspension (200-400 ugmg protein), 10~eM C3H3PIA in
a final volume of 200 ul. Whenever required, drugs or
membrane preincubated ginseng extract were added as indicated
in the Table. The mixture was incubated at 37°C for 20 min
with continous shaking. Reaction was terminated by dilution
with 1 ml of ice-cold incubation buffer followed by rapid
filtration through GFC filter. The filter was immediately
washed twice with 5 ml of ice-cold incubation buffer, oven
dried and radioactivity determined.
Total binding was measured in the presence of
[3H3PIA (10 8M, specific activity, 42 Cimmol) and non¬
specific binding was taken as the C3H3PIA bound in the
presence of 10 4f1 of PI A-
Each value represents the means± S-D- of
triplicate determinations and results were expressed as total
C3H3PIA bound. Statistical analysis was performed by the
Students' t~test and the results were found to be
statistically not significant.
Table 3.9 Effect Ql ginseng total saponins and purinergic-
related compounds on tota1r3 hiPhenv1isopropv1-
adenosine (C3H1PTA) binding in cardiac membrane
Pretreated Hith adenosine deaminase













































































radioligand binding was relatively small though the
membranes had been extensively washed with buffer during
the isolation procedure to remove as much as possible the
endogenous adenosine which might have been associated with
the membranes. Though the presence of endogenous adenosine
is slight; nevertheless, membranes were pretreated with
adenosine deaminase (1 and 5 mgml) to remove the endogenous
adenosine that might have been associated with the membrane.
In the adenosine deaminase-treated membranes, the
amount of C3H3PIA bound was about 1.5 fold higher than the
untreated membrane (Table 3-9)5 however, the amount of
radioligand binding was still low compared to that of other
tissue (Trost and Schwabe, 1980)- Similar to the untreated
membranes, the pretreatment of cardiac membranes with
adenosine deaminase did not change the displacement of
labeled PIA by unlabeled PIA adenosine and other
purinergic-related compounds as well as ginseng total
saponins. This suggests that despite the membrane had been
extensively washed during the preparation there is still
some adenosine or adenosine-related compound associated
with the membranes. Under essentially similar conditions,
the binding of C3HI]PIA was found to be effectively displaced
by unlabeled PIA and adenosine at the concentration of 10 M
in rat synaptic membranes( D« Tsang, private
communication). This implied that the [3H1PIA used in this
assay was chemically stable suggesting that C3H]PIA may not
be a suitable radioligand for adenosine receptor assay in
cardiac membranes. To further assess the adensosine
receptors in cardiac membranes, C3HDadenosine was chosen as
the radioligand since this has been used successfully to
demonstrate the high affinty adenosine binding sites in rat
fat cell membranes (Malbon m., 1978) and in mammalian
brain tissues (Newman Jil.j 1981).
3-6 Effect Ql ginseng tQtgl saponins and purinergic-
relPted compounds on r3H1adenosine binding
Ginseng extract at various concentrations and
several purinergic-related compounds were tested for their
effects on C3Hladenosine binding in cardiac membranes (Table
3.10). When [3H3adenosine (10 SM) was incubated with
cardiac membrane in the presence of increasing
concentrations of unlabeled adenosine, 52% of dispalcement
of C3H!]adenosine bound was observed with 10 M of
adenosine. A similar order of effectiveness was observed
for the displacement of binding by ATP which has been
shown to be an adenosine receptor agonist (Burnstock, 1978).
However, no significant displacement of [3HUadenosine was
seen with 10 M of PIA- This finding again confirms our
doubt whether PIA is a suitable ligand for characterising
adenosine receptors in cardiac membranes It seems that
adenosine is a more suitable ligand for the assay of cardiac
adenosine receptors than PIA- However, enzymatic breakdown
of adenosine to inosine during the incubation was likely to
Table 3-10 Fffeet of ginseng total saponins and Perinergic-
related compounds so r3 Hladenosine binding
The binding assay was carried out as described in
Table 3-9- Total binding was measured in the presence of
[3HDadenosine (10~8M specific activity, 45 Cimmol) and
non-specific binding was taken as the [3H]adenosine bound in
the presence of 10~M of adenosine- Specific binding was
obtained by substracting the non-specific binding from the
total binding.,
Each value represents the mean+ S-D- of triplicate
determinations and results were expressed as% specific
C3H]adenosine bound- Statistical analysis was performed by
the Students' t-test: d n.m and P 0-001 compared
with the control-
Table 3.10 FTfeet fif ginseng total saponins md Purinergic-
relqted compounds an r3HTadenosine binding























































occur because displacement of binding was also observed with
increasing concentrations of inosine, but the extent to
which displacement occurred was smaller with inosine than
adenosine. Theophylline and caffeine, which inhibit
adenosine binding in other tissues (Malbon££ al., 19785
Newman _£t ,g_L., 1981) did not substantially compete with the
binding of the radioligand. The reason is unclear and it is
not known whether tissue difference may be the reason.
Fi9ure 3-9 shows the inhibitory effect
of ginseng total saponins on [3HUadenosine binding. Under
the same experimental conditions as [3HDPIA binding, ginseng
total saponins inhibited [3HUadenosine binding and
significant inhibition of [3HUadenosine binding was observed
with as low as 50 ugml of ginseng extract. To minimize the
degradation of the [3HUadenosine during incubation by the
possible presence of adenosine deaminase associated with the
membranes, the binding assay was also carried out at 0°C and
the results were shown in Table 3-11- Lowering of the
incubation temperature did not alter the inhibitory action
of ginseng total saponins on [3HUadenosine binding though
the amount of C3HUadenosine bound was smaller than at 37°C
and significant inhibition was observed with much lower
concentration of ginseng total saponins. As previous
experiments on [3HUPIA binding studies (Table 3-9) showed
that [3HUPIA binding was increased following pretreatment
with adenosine deaminase, the effect of ginseng total
saponins and purinergic-related compounds on [3HUadenosine
Fi9ure 3-9 Effect of ginseng total saponins on
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Table 3.11 ginseng total saponins AM
Hladenosine binding
Ginseng total saponins Total [3H]adenosine bound










The binding assay was carried out at 0°C and the
procedures were essentially the some as described in table
3.9. Each value represents the mean± S.D. of triplicate
determinations and results were expressed as total
[3H3adenosine bound. Statistical anayysis was performed by
the Students' t-test: *p 0.01 and **P 0.001
compared with the control.
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binding in cardiac membranes pretreated with the enzyme
(1 and 5 mg/ml) was examined to see if adenosine deaminase
treatment might remove the endogenous adenosine associated
with the membrane preparation. In the adenosine deaminase-
treated membranes, specific binding was about 4-fold higher
than the untreated membranes, whereas the non-specific
binding was not changed (Table 3.12). When the
concentration of adenosine deaminase was increased to 5
mg/ml, specific binding was further increased suggesting
that there may be some endogenous adenosine associated with
the cardiac membranes. As depicted in Table 3.12,
pretreatment of membrane with adenosine deaminase did not
alter the effect of purinergic-related compounds and ginseng
total saponins on [3H]adenosine binding, and significant
inhibition of C3H]adenosine binding was observed with
0.25 ug/ml of ginseng total saponins. Moreover, the
inhibition was dose-dependent.
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Table 3.12 Fffect of ginseng total saponins and purinergic-
related compounds on C3H]adenosine binding in
cardiac membranes treated with adenosine
deaminase
The binding assay was carried out as described in
the Table 3.9. Each value represents the mean± S.D. of
triplicate determinations. Statistical analysis was
performed by the Students' t-test: *p 0.01 and •*p 0.001
compared with the control.
Table 3.12 Effect Hf Qinseng total saponins and purinergic-
relqted compounds AO C3Hladeaosine binding in
cardiac membranes treated with adenosine
deaminase
PomDOund added





















































































































In the present study the possible action of
ginseng total saponins on the heart was investigated by
Physiological and biochemical means- Using isolated
perfused rat heart it was found that ginseng total saponins
had a positive inotropic action on the heart- To date,
three possible mechanisms are thought to be operative in
controlling the positive inotropic action- These mechanisms
include the stimulation of calcium influx (Langer, 1965)s
activation of 3 -adrenergic receptor (Lefkowitz and
Williams, 1977) and inactivation of adenosine receptor
(Schrader et al-j 1977).
In cardiac muscle flux of calcium across the
plasma membrane is an essential feature of excitation-
contraction coupling (Brady, 1964). Calcium entering the
cell is thought to provide a trigger for the release of
calcium from intracellular stores, thereby increasing the
free intracellular calcium concentration which in turn
causes contraction of actomyosin myofilaments via binding to
the tropinin component (Katz, 1970). In skeletal muscle
much of this calcium is derived from internal stores
(Winegrade, 1970). Cellular calcium exchange in skeletal
muscle occurs at a slow rate and reacts slowly to
alterations of the external calcium concentration (Rich and
Longer, 1975). Therefore, in skeletal muscle, effective
excitation-contraction coupling occurs irrespective of the
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presence of extracellular calcium. This situation contrasts
with that which occur in cardiac muscle, where excitation-
contraction coupling fails unless the fluid -bathing the
extracellular surface of the cell membrane contains calcium.
This absolute requirmemt for calcium in the extracellular
fluid may mean that the calcium that is involved in
excitation-contraction coupling originates directly from the
extracellular fluid.
In the present study, calcium uptake in
ventricular slices and sarcoplasmic reticulum was examined
to see if ginseng total saponins may exert its positive
inotropic effect by altering calcium fluxes. Physiological
study on the possible effect of ginseng total saponins on
calcium channel was not investigated due to the lack of
selective calcium blocker in our laboratory. Results
indicated that ginseng extract facilitated calcium uptake in
ventricular slices but no dosage dependence was observed.
This suggests that ginseng total saponins may exert its
positive inotropic effect by stimulation of calcium influx.
As the lowest dosage tested was 0.05 ug/ml, it is not clear
whether this concentration of ginseng extract has already
induced the maximum response. Further studies are required
to clarify this point. As no stimulation of calcium uptake
was observed in the sarcoplasmic reticulum, this is in line
with the thought that this subcellular organelle does not
store much calcium (Winegra-de, 1970). As the study on the
calcium fluxes is rather preliminary, further studies are
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required to substantiate the action of ginseng total
saponins on calcium fluxes by applying calcium antagonists
such as verapamil or pyrenylamine to isolated perfused heart
preparation.
In view of the present proposal concerning the
role of calcium in cardiac excitation-contraction coupling
which suggests that there is an absolute requirememt of
extracellular calcium, the present finding seems to suggest
that ginseng total saponins may exert its positive inotropic
action by stimulating the influx of calcium from the
extracellular fluid. The result obtained with ventricular
sarcoplasmic reticulum is in contrast with the report on
rabbit aortic sarcoplasmic reticulum by Lee (1980) who
showed that ginseng inhibited calcium uptake. The
difference is likely due to the fact that aortic strips are
smooth muscle cells which contain fairly large sarcoplasmic
reticulum and that this organelle acts as a calcium store in
this tissue, while the sarcoplasmic reticulum in cardiac
cells is very different. Other factors which may contribute
to the difference include the type of ginseng used---
Korean ginseng was used in the aortic strips study while
Kirin ginseng was used in this study. Thus, the lack of
effect of ginseng total saponins on calcium influx in the
cardiac sarcoplasmic reticulum may be expected as this
subcellular organelle does not contribute much calcium in
the excitation-contraction coupling in the heart.
Considering the effects of ginseng total saponins on the
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heart and aortic strip together, it seems to suggest that
ginseng extract may affect the cardiovascular system by
influencing the availability of calcium in the_ excitation-
contraction coupling.
One of the mechanisms that controls the inotropic
activity in the heart is believed to be mediated by the
adrenergic receptors (Lefkowitz and Williams, 1977). In the
rat heart studies with -selective and 2-selective drugs
indicate that 90% of the 13-adrenergic receptors are of the
131-subtype however, it is unclear whether these 131-subtype
receptors regulate different physiological responses or
not (Minneman et., 1979). Studies on other tissues also
indicate that both i -and 2 -adrenergic receptors
co-exist and may mediate the same physiological response and
it is hypothesized that the pharmacological specificity of a
particular response depends on the ratio of 1/ 2 receptors
mediating that response as well as the relative affinities
of the two types of receptors for the drug in question
(Furchgott, 1978). Since the stimulation of -adrenergic
receptors in the heart can be blocked by -adrenergic
blockers, irrespective of the manner in which that
stimulation is evoked, the possibility that activation of
-adrenergic receptors may be responsible for the positive
inotropic effect of ginseng total saponins was examined with
two cardioselective -blockers namely metoprolol and
atenolol. However, the blockade of -adrenergic receptors
with either of these two selective -blockers did not
significantly shift the dose response curve to the right
suggesting that ginseng total saponins does not affect
cardiac contractility by interacting with gx -adrenergic
receptors- However, when this question was investigated
using radioligand binding technique, the phenomenon observed
is different- Si9nificant inhibition of C3H!1DHA binding was
observed with high doses of ginseng extract, and this
inhibitory action may possibly arise from the fact that
ginseng total saponins have detergent action. However, when
the cardiac membranes were preincubated with ginseng extract
for 10 min, inhibition of C3HJDHA binding was observed with
all doses of ginseng extract (0.25-2000 ugml) tested- As
significant inhibition was observed with 0-25 ugml of
ginseng extract, it seems unlikely that the surfactant
effect of ginseng total saponins can account for the
observed inhibition fully. This doubt is strengthened by
the finding that ginseng extract affected the uptake of
neurotransmitters and substrates differentially (Tsang
aI-, 1985) though the possibility that ginseng total
saponins may affect different tissues differentially cannot
be excluded. As the positive inotropic effect of ginseng
total saponins was not blocked by metoprolol or atenolol and
that low doses of ginseng total saponins failed to alter the
binding of C3H3DHA when both were added to the incubation
mixture simultaneously, it appears that ginseng total
saponins do not affect cardiac contractility by interacting
with 3 -adrenergic receptors directly. The inhibition of
3
C H3DHA binding observed in membranes preincubated with low
doses of ginseng extract may be due to the possible action
of the extract on the membranes at sites close to the
C3H!1DHA binding sites. The failure of ginseng total saponins
to alter C 3HDDHA binding when both were added to the
incubation mixture simultaneously may be due to the
protection of the 3-adrenergic receptor microenvironmemt by
the presence of DHA- Similar phenomenon has been
demonstrated in various membrane preparations in which the
binding sites can be protected from enzymatic degradation if
the sites are protected by specific agonists or antagonists
CHiller and Simon, 1976) This thought is in line with the
conclusion that ginseng total saponins does not interact
with the adrenergic receptor directly and that ginseng total
saponins does not exert its positive inotropic effect by
interacting with adrenergic receptors. The physiological
and pharmacolgical significance of the effect of ginseng
extract on the microenvironment remain to be investigated.
jhe present finding disagrees with the previous
report of Kim jet _Ql-(1980) who showed that pretreatment with
propranolol abolished the positive inotropic effect of
ginsenosides R. This discrepancy may be due to the fact
bi
that propranolol, a non—selective 3 —blocker, was used and
at fairly high concentrations. As propranolol antagonizes
both 31-receptors and the 32-receptors while 90% are of
the 3 -adrenergic receptors in the heart muscle are of the
3X -subtypes (Minneman Hi- 1979)» this raises the
question about the specificity of the inhibition observed
with propranolol in the experiment by Kim££ jal-(1980).
Since the publication by Drury and Szent-Gyorgyi
in 1929 there has been growing recognition that ATP and
related compounds may have potent extracellular actions on
excitable membranes and that these may be involved in
Physiological regulatory mechanisms (Burnstock, 19725
Riberio, 1978)- Of particular interest are the proposals by
Berne (1963) that adenosine is a physiological regulator of
blood flow in the heart, and by Burnstock (1972) that ATP or
a related purine nucleotide is the neurotransmitter
substance in nonadrenergic, noncholinergic, purinergic
nerves. Adenosine exerts important metabolic actions on the
myocardium (Buckley, 1970) in addition to its well known
effect on coronary blood flow. The cardiac effects of
adenosine include negative inotropic (Schroder Hi- 1977)
and chronotropic actions (Stafford, 1966)- In the present
study, the possible interaction between adenosine receptors
and ginseng total saponins was examined.
It has suggested that adenosine may not be a
suitable ligand to characterise adenosine receptor (Schwabe
and Trost, 1980)- This is because unlike its analogues,
uptake and metabolism are major complications when adenosine
is used in pharmacological and biochemical studies.
Furthermore, unlike its analogues, adenosine acts at both
adenosine receptors and P sites (Murphy and Snyder, 1981).
In the present pilot study, [3HDPIA was chosen as the
Ii9and to investigate adenosine receptors in rat myocardium
as this analogue is not subject to metabolism by adensoine
deaminase and which has an affinity for adenosine receptors
greater than adenosine itself. Moreover reports about the
radioreceptors assay for adenosine receptor in myocardium
have not been described. Despite its successful use in
brain and adipose tissues C3H3PIA may not be a suitable
analogue to characterize adenosine receptors in the
myocardium since no displacement of [3HUPIA was observed in
the presence of increasing concentrations of unlabeled PIA
and adenosine in addition to the low amount of[ 3 H3PIA
bound. Though the use of adenosine deaminase treatment has
been proven an useful technique for probing adenosine
receptors in various tissues (Schwabe and Trost 1980)
however, this procedure did not change the amount of
specific Q 3H3PIA bound by adenosine and PIA despite there
was an increase in the amount of total C3H3PIA bound. Since
C 3H3PIA is resistant to deamination by the deaminase
(Schwabe and Trost, 1980) and the membranes were extensively
washed following deaminase treatment it is unlikely that
the failure of PIA adenosine and other purinergic related
compounds to displace the C3H3PIA could be due to the
possibility that the [3H3PIA added was metabolized by the
adenosine deaminase. It seems that the [3HDPIA associated
with the cardiac membranes might have been bound to some
non-specific sites of unknown nature. If this is true, it
would suggest that C3H3PIA may not be a suitable radioligand
to assay adenosine receptors in the myocardium.
As information concerning the suitability of
adenosine analogues for adenosine receptor assay is
extremely limited (Murphy and Synder, 1981), it was decided
to test the possibilty of using [3HUadenosine in assaying
adenosine receptors in the myocardium despite knowing that
the radioligand can be metabolized by the adenosine
deaminase that might have been associated with the cardiac
membrane preparation. To minimize this shortcoming, the
membrane was washed extensively with 30 volumes of buffer
twice during the final stage of the membrane isolation
procedure.
It appears that [3HDadenosine is a better ligand
than C 3HDPIA for the study of adenosine receptors in the
myocardium as 52% of the radioactive bound can be displaced
in the presence of 10 M of adenosine. To test the
specificity of [3H3adenosine binding to cardiac membranes,
the binding of [3HDadenosine was assayed in the presence of
various purinergic related compounds. As shown in Table
3.10 PIA was ineffective as a competitor for adenosine
binding to the membrane whereas ATP and inosine were very
potent. These data seem to suggest that PIA does not bind
to adenosine receptors. Unlike its action in fat cells,
theophylline did not inhibit adenosine binding to cardiac
membranes. The inability of theophylline to effectively
compete for binding sites with C3H:adenosine suggests that
theophylline is a poor inhibitor in rat cardiac membranes.
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The possibilty that the presence of endogeneous
adenosine may be responsible for the observed low binding
was examined by pretreating the membranes with adenosine
deaminase followed by two extensive washings to remove or
reduce the enzyme associated with the membranes. After the
treatment, the amount of specific C3H] adenosine bound was
found to be 4-fold higher which suggests that some of the
sites are occupied by endogenous adenosine. As inosine, a
degradative product of adenosine, is also fairly effective
in lowering [3H]adenosine binding, the possibility that some
of the [3H]adenosine have been converted to [3H]inosine
and other adenosine metabolites cannot be excluded. This
calls for a more detail study regarding to suitability of
[ 3H]adenosine for assaying adenosine receptors in the
myocardium though C 3 H]adenosine has been used to
characterize adenosine receptors in other tissues (Newman et
p1., 1951). Despite some possible shortcomings associated
with this study, ginseng total saponins was found to
inhibit the binding of C3H]adenosine to cardiac membranes in
a dose dependent manner and significant inhibition was
observed with 0.25 ug/ml of ginseng total saponins (Table
3.12). Similar inhibition was observed at 0°C (Table 3.11)
at which it was believed to have minimized the degradation
of the added [3H]adenosine by the adenosine deaminase that
might have been associated with the membrane preparation.
If the radioactivity bound is still mainly due to [3H]-
adenosine, the inhibition seen in the presence of ginseng
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total saponins would suggest that the ginseng extract may
exert its effect by interacting with cardiac adenosine
receptors. Since it has been proposed that adenosine has a
negative inotropic and chronotropic effects in myocardium,
the increase in contractility observed with ginseng extract
may be due to the effect of ginseng total saponins on the
cardiac adenosine receptors. As the some ginseng extract,
at similar concentrations used in this study, did not affect
the binding of [ 3HJPIA] or [3H]adenosine to synaptic
membranes (0. Tsang, private communication), this argues
against the effect seen with ginseng extract on C3H]-
adenosine binding in cardiac membranes is due to the
surfactant effect of ginseng total saponins.
If ginseng total saponins does indeed exert its
positive inotropic effect by inactivating adenosine
receptors in the heart, it raises the question concerning
the pharmacological and physiological significances of the
present finding. It is known that under physiological
conditions, the endogenous adenosine is maintained within
very low levels (1-2 uM) by the action of adenosine
deaminase (Katori and Berne, 1966). Considerable evidence,
however, indicates that myocardial adenosine formation
increases when 02 delivery is diminished (e.g. ischaemia or
hypoxia). This proposal is based on the finding that the
amount of adenosine found in the effluent from hypoxic heart
in the presence of an adenosine deaminase inhibitor was
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increased (Katori and Berne, 1966). Therefore, under
hypoxia or ischaemia, the rate of adenosine formation is
comparatively higher in the heart, and this increase in
adenosine in the effluent is accompanied by parallel
decrease in cardiac contractility (Berne, 1963).
In the present study why do we observe an effect
of ginseng total saponins in the isolated perfused heart
then? One likely explanation is that the isolated perfused
heart preparation used in this study is in an ischaemic
condition as the heart was perfused at a flow rate of 5-8
ml/min in the constant pressure model which is significantly
lower than the rate required for the maintenance of proper
cardiac performance in an isolated perfused heart
preparation. In order to maintain proper functioning of the
heart, Koo et al. (1979) have estimated that a flow rate of
10-12m1/min is required. Thus, it seems possible that under
such an ischaemic condition, the amount of endogeneous
adenosine in the preparation may be increased and this
elevation in adenosine may reduce the contractility of the
heart, and ginseng total saponins by interacting with the
adenosine receptors alleviates the negative inotropic effect
of adenosine. This speculation is in line with the general
belief that ginseng exerts its beneficial effect more
significantly when the patient is under adversed conditions.
In conclusion, the present study suggests that ginseng total
saponins may exert its action in the heart possibly by
increasing the influx of calcium and interacting with the
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